593 related articles for article (PubMed ID: 29654866)
1. Effects of the beta
Salazar-Degracia A; Busquets S; Argilés JM; Bargalló-Gispert N; López-Soriano FJ; Barreiro E
Biochimie; 2018 Jun; 149():79-91. PubMed ID: 29654866
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness.
Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E
J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622
[TBL] [Abstract][Full Text] [Related]
3. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
[TBL] [Abstract][Full Text] [Related]
4. Differential structural features in soleus and gastrocnemius of carnitine-treated cancer cachectic rats.
Busquets S; Pérez-Peiró M; Salazar-Degracia A; Argilés JM; Serpe R; Rojano-Toimil A; López-Soriano FJ; Barreiro E
J Cell Physiol; 2020 Jan; 235(1):526-537. PubMed ID: 31241186
[TBL] [Abstract][Full Text] [Related]
5. Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.
Salazar-Degracia A; Busquets S; Argilés JM; López-Soriano FJ; Barreiro E
PeerJ; 2017; 5():e4109. PubMed ID: 29255650
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Akt-mTOR, ubiquitin-proteasome and autophagy-lysosome pathways in response to formoterol administration in rat skeletal muscle.
Joassard OR; Amirouche A; Gallot YS; Desgeorges MM; Castells J; Durieux AC; Berthon P; Freyssenet DG
Int J Biochem Cell Biol; 2013 Nov; 45(11):2444-55. PubMed ID: 23916784
[TBL] [Abstract][Full Text] [Related]
7. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
8. Formoterol fumarate and roxithromycin effects on muscle mass in an animal model of cancer cachexia.
Kenley RA; Denissenko MF; Mullin RJ; Story J; Ekblom J
Oncol Rep; 2008 May; 19(5):1113-21. PubMed ID: 18425366
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic and metabolic features of mouse diaphragm and gastrocnemius muscles in chronic lung carcinogenesis: influence of underlying emphysema.
Salazar-Degracia A; Blanco D; Vilà-Ubach M; de Biurrun G; de Solórzano CO; Montuenga LM; Barreiro E
J Transl Med; 2016 Aug; 14(1):244. PubMed ID: 27549759
[TBL] [Abstract][Full Text] [Related]
10. Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis.
Gómez-SanMiguel AB; Gomez-Moreira C; Nieto-Bona MP; Fernández-Galaz C; Villanúa MÁ; Martín AI; López-Calderón A
Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E925-37. PubMed ID: 27245339
[TBL] [Abstract][Full Text] [Related]
11. Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting.
Busquets S; Figueras MT; Fuster G; Almendro V; Moore-Carrasco R; Ametller E; Argilés JM; López-Soriano FJ
Cancer Res; 2004 Sep; 64(18):6725-31. PubMed ID: 15374990
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Approaches in Mitochondrial Dysfunction, Proteolysis, and Structural Alterations of Diaphragm and Gastrocnemius in Rats With Chronic Heart Failure.
Barreiro E; Puig-Vilanova E; Marin-Corral J; Chacón-Cabrera A; Salazar-Degracia A; Mateu X; Puente-Maestu L; García-Arumí E; Andreu AL; Molina L
J Cell Physiol; 2016 Jul; 231(7):1495-513. PubMed ID: 26530247
[TBL] [Abstract][Full Text] [Related]
13. Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist.
Toledo M; Busquets S; Penna F; Zhou X; Marmonti E; Betancourt A; Massa D; López-Soriano FJ; Han HQ; Argilés JM
Int J Cancer; 2016 Apr; 138(8):2021-9. PubMed ID: 26595367
[TBL] [Abstract][Full Text] [Related]
14. Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats.
Busquets S; Toledo M; Marmonti E; Orpí M; Capdevila E; Betancourt A; López-Soriano FJ; Argilés JM
Oncol Lett; 2012 Jan; 3(1):185-189. PubMed ID: 22740878
[TBL] [Abstract][Full Text] [Related]
15. Curcumin and Resveratrol Improve Muscle Function and Structure through Attenuation of Proteolytic Markers in Experimental Cancer-Induced Cachexia.
Penedo-Vázquez A; Duran X; Mateu J; López-Postigo A; Barreiro E
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443492
[TBL] [Abstract][Full Text] [Related]
16. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, redox signaling pathways, and autophagy in cachectic muscles of male patients with advanced COPD and lung cancer.
Puig-Vilanova E; Rodriguez DA; Lloreta J; Ausin P; Pascual-Guardia S; Broquetas J; Roca J; Gea J; Barreiro E
Free Radic Biol Med; 2015 Feb; 79():91-108. PubMed ID: 25464271
[TBL] [Abstract][Full Text] [Related]
18. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
[TBL] [Abstract][Full Text] [Related]
19. Myostatin is a novel tumoral factor that induces cancer cachexia.
Lokireddy S; Wijesoma IW; Bonala S; Wei M; Sze SK; McFarlane C; Kambadur R; Sharma M
Biochem J; 2012 Aug; 446(1):23-36. PubMed ID: 22621320
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction and therapeutic approaches in respiratory and limb muscles of cancer cachectic mice.
Fermoselle C; García-Arumí E; Puig-Vilanova E; Andreu AL; Urtreger AJ; de Kier Joffé ED; Tejedor A; Puente-Maestu L; Barreiro E
Exp Physiol; 2013 Sep; 98(9):1349-65. PubMed ID: 23625954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
